In this work, we contribute a multi-institutional series of three further cases of IHG harboring this particular RTK gene fusion, aiming to comparatively illustrate the clinico-pathological characteristics of TRIM24::MET fusion-driven IHG and expand the spectrum of renowned recurrent MET gene fusions in pediatric gliomas. The gene discussed is TRIM24; the disease is central nervous system cancer.